APVO

Conviction 12HealthcareScan · Mon, Aug 10, 2026

APVO$4.04-3.35%

ResistanceSupportVol 14

Vol MA14 13.66K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Aptevo Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.aptevotherapeutics.com ↗

Price4.04

Change-3.35%

Gap+0.00%

Rel volume0.06×

Avg volume21.3K

Avg $ vol93.95K

SMA 204.30

SMA 504.51

SMA 2004.57

Price vs 50-10.37%

Price vs 200-11.68%

MA stackbearish

50/200 crossdeath · 2d

Supertrenddown · 4.77

RSI (14)42

MACD hist-0.00

MACD cross—

Stoch %K / %D21 / 26

ADX (14)14

+DI / −DI17 / 24

RSI divergence—

MACD divergence—

ATR %+6.06%

ADR %5.61%

52w high9.83

52w low0.5499

From 52w high-58.90%

Above 52w low+634.68%

New 52w highNo

SqueezeOff

Bollinger width22.44%

%B0.23

Donchian pos14.00%

Donchian high4.90

Donchian low3.90

AVWAP (52w high)5.29

vs AVWAP high-23.66%

AVWAP (52w low)3.75

vs AVWAP low+7.80%

OBV trendFlat

Chaikin MF (20)0.23

Today vs 20d0.06×

Avg vol (14d)13.66K

Avg vol (20d)21.3K

Avg $ vol (20d)93.95K

Market cap—

RS 3m (vs SPY)-19.69%

RS 6m (vs SPY)-44.56%

RS line new highNo

Trend template3/8

Technical rank14.5

1 week+2.28%

1 month+2.54%

3 months-18.71%

6 months-39.70%

1 year+88.79%

YTD-56.98%

P/E-0.20

P/B0.45

P/S1.68

P/FCF-0.20

EPS-87.27

Div yield—

ROE-223.62%

ROA-130.47%

Debt/Eq0.30

Current3.36

EV/EBITDA0.22

Gross margin—

Net margin-833.88%

Rev growth0.00%

EPS growth-7.61%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-5.85M

Revenue3.11M

Net income-6.7M

Gross profit—

Free cash flow-25.62M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.25M

Employees33

ListedWed, Jul 20, 2016

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank14.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.91

Support3.79

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APVO

All disclosures →

No recent disclosed trades by Congress in APVO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APVO

No recent insider (Form 4) filings in APVO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in APVO · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.